Clinical and laboratory parameters in dapsone acute intoxication
Autor(a) principal: | |
---|---|
Data de Publicação: | 2000 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista de Saúde Pública |
Texto Completo: | https://www.revistas.usp.br/rsp/article/view/25039 |
Resumo: | OBJECTIVE: To determine the severity of dapsone (DDS) acute intoxication – an uncommon medical event – using clinical and laboratory parameters. METHODS: Two hundred and seventy four patients with acute DDS intoxication, aged 1 month to 50 years old, were studied and classified into four age groups. Clinical evaluation was assessed through a protocol and correlated with laboratory parameters. Spectrophotometric methods were used to analyze methemoglobinemia (MHbp) and dapsonemia (DDSp). RESULTS: The most prevalent clinical sign of intoxication was cyanosis, seen in 65.7% of the patients and in 100% of children less than 5 years of age. According to laboratory criteria, MHbp-related severe clinical intoxication was seen in 56.2% and DDSp-related occurred in 58% of the patients. Regarding DDSp, intoxication was considered severe when 20 tablets (100 mg each) were ingested, a median of 29 mug/ml. Regarding MHbp, intoxication was severe when 7.5 tablets were ingested, a median of 38% of the total Hb. The correlation between MHbp and DDSp was statistically significant (n=144, r=0.32, p |
id |
USP-23_b6d98ed4ea81472bc232aa5ccbcabd47 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/25039 |
network_acronym_str |
USP-23 |
network_name_str |
Revista de Saúde Pública |
repository_id_str |
|
spelling |
Clinical and laboratory parameters in dapsone acute intoxication Parâmetros clínicos e laboratoriais na intoxicação aguda pela dapsona Dapsona^i2^senvenenameMetemoglobinemia^i2^ssanCianoseIntoxicação agudaDapsone^i1^spoisonMethemoglobinemia^i1^sblCyanosisIntoxicationacute OBJECTIVE: To determine the severity of dapsone (DDS) acute intoxication – an uncommon medical event – using clinical and laboratory parameters. METHODS: Two hundred and seventy four patients with acute DDS intoxication, aged 1 month to 50 years old, were studied and classified into four age groups. Clinical evaluation was assessed through a protocol and correlated with laboratory parameters. Spectrophotometric methods were used to analyze methemoglobinemia (MHbp) and dapsonemia (DDSp). RESULTS: The most prevalent clinical sign of intoxication was cyanosis, seen in 65.7% of the patients and in 100% of children less than 5 years of age. According to laboratory criteria, MHbp-related severe clinical intoxication was seen in 56.2% and DDSp-related occurred in 58% of the patients. Regarding DDSp, intoxication was considered severe when 20 tablets (100 mg each) were ingested, a median of 29 mug/ml. Regarding MHbp, intoxication was severe when 7.5 tablets were ingested, a median of 38% of the total Hb. The correlation between MHbp and DDSp was statistically significant (n=144, r=0.32, p OBJETIVO: Definir a gravidade da intoxicação aguda por dapsona (DDS) – uma ocorrência médica não usual – usando parâmetros clínicos e laboratoriais. MÉTODOS: Foram estudados 274 pacientes intoxicados por DDS, divididos em quatro grupos etários; as idades variaram de um mês a 50 anos. A avaliação clínica foi efetuada por meio de um questionário e correlacionada com parâmetros laboratoriais. A metemoglobinemia (MHbp) e a dapsonemia (DDSp) foram analisadas por métodos espectrofotométricos. RESULTADOS: O sinal clínico mais prevalente da intoxicação foi a cianose, presente em 65,7% dos pacientes e em 100% das crianças menores de 5 anos. A intoxicação grave, definida laboratorialmente, de acordo com a MHb ocorreu em 56,2% dos pacientes e, de acordo com a DDSp, em 58%. A intoxicação foi grave, de acordo com a DDSp, quando houve a ingestão mediana de 20 comprimidos (100mg cada) e, de acordo com a MHbp, quando a ingestão foi de 7,5 comprimidos. A mediana de MHbp foi de 38% da Hb total. A correlação entre MHbp e a DDSp foi significativa (n=144, r=0,32, pUniversidade de São Paulo. Faculdade de Saúde Pública2000-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rsp/article/view/2503910.1590/S0034-89102000000400013Revista de Saúde Pública; Vol. 34 No. 4 (2000); 396-401 Revista de Saúde Pública; Vol. 34 Núm. 4 (2000); 396-401 Revista de Saúde Pública; v. 34 n. 4 (2000); 396-401 1518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/rsp/article/view/25039/26866Copyright (c) 2017 Revista de Saúde Públicainfo:eu-repo/semantics/openAccessCarrazza, Maria Zilda NCarrazza, Francisco ROga, Seizi2012-05-29T18:46:31Zoai:revistas.usp.br:article/25039Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2012-05-29T18:46:31Revista de Saúde Pública - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Clinical and laboratory parameters in dapsone acute intoxication Parâmetros clínicos e laboratoriais na intoxicação aguda pela dapsona |
title |
Clinical and laboratory parameters in dapsone acute intoxication |
spellingShingle |
Clinical and laboratory parameters in dapsone acute intoxication Carrazza, Maria Zilda N Dapsona^i2^senvenename Metemoglobinemia^i2^ssan Cianose Intoxicação aguda Dapsone^i1^spoison Methemoglobinemia^i1^sbl Cyanosis Intoxication acute |
title_short |
Clinical and laboratory parameters in dapsone acute intoxication |
title_full |
Clinical and laboratory parameters in dapsone acute intoxication |
title_fullStr |
Clinical and laboratory parameters in dapsone acute intoxication |
title_full_unstemmed |
Clinical and laboratory parameters in dapsone acute intoxication |
title_sort |
Clinical and laboratory parameters in dapsone acute intoxication |
author |
Carrazza, Maria Zilda N |
author_facet |
Carrazza, Maria Zilda N Carrazza, Francisco R Oga, Seizi |
author_role |
author |
author2 |
Carrazza, Francisco R Oga, Seizi |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Carrazza, Maria Zilda N Carrazza, Francisco R Oga, Seizi |
dc.subject.por.fl_str_mv |
Dapsona^i2^senvenename Metemoglobinemia^i2^ssan Cianose Intoxicação aguda Dapsone^i1^spoison Methemoglobinemia^i1^sbl Cyanosis Intoxication acute |
topic |
Dapsona^i2^senvenename Metemoglobinemia^i2^ssan Cianose Intoxicação aguda Dapsone^i1^spoison Methemoglobinemia^i1^sbl Cyanosis Intoxication acute |
description |
OBJECTIVE: To determine the severity of dapsone (DDS) acute intoxication – an uncommon medical event – using clinical and laboratory parameters. METHODS: Two hundred and seventy four patients with acute DDS intoxication, aged 1 month to 50 years old, were studied and classified into four age groups. Clinical evaluation was assessed through a protocol and correlated with laboratory parameters. Spectrophotometric methods were used to analyze methemoglobinemia (MHbp) and dapsonemia (DDSp). RESULTS: The most prevalent clinical sign of intoxication was cyanosis, seen in 65.7% of the patients and in 100% of children less than 5 years of age. According to laboratory criteria, MHbp-related severe clinical intoxication was seen in 56.2% and DDSp-related occurred in 58% of the patients. Regarding DDSp, intoxication was considered severe when 20 tablets (100 mg each) were ingested, a median of 29 mug/ml. Regarding MHbp, intoxication was severe when 7.5 tablets were ingested, a median of 38% of the total Hb. The correlation between MHbp and DDSp was statistically significant (n=144, r=0.32, p |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/25039 10.1590/S0034-89102000000400013 |
url |
https://www.revistas.usp.br/rsp/article/view/25039 |
identifier_str_mv |
10.1590/S0034-89102000000400013 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/25039/26866 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2017 Revista de Saúde Pública info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2017 Revista de Saúde Pública |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
dc.source.none.fl_str_mv |
Revista de Saúde Pública; Vol. 34 No. 4 (2000); 396-401 Revista de Saúde Pública; Vol. 34 Núm. 4 (2000); 396-401 Revista de Saúde Pública; v. 34 n. 4 (2000); 396-401 1518-8787 0034-8910 reponame:Revista de Saúde Pública instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Revista de Saúde Pública |
collection |
Revista de Saúde Pública |
repository.name.fl_str_mv |
Revista de Saúde Pública - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
revsp@org.usp.br||revsp1@usp.br |
_version_ |
1800221779297304576 |